Study of Cabozantinib (XL184) Versus Prednisone in Men With Metastatic Castration-resistant Prostate Cancer Previously Treated With Docetaxel and Abiraterone or MDV3100
Clinical trial NCT01605227 · COMPLETED
Trial details
- NCT number
- NCT01605227
- Sponsor
- Exelixis
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-01
- Primary completion
- 2014-09-01
- Enrollment
- 1028
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.